More Answers

Gemtuzumab ozogamicin

en.wikipedia.org/wiki/Gemtuzumab_ozogamicin

Gemtuzumab ozogamicin (marketed by Wyeth as Mylotarg) is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute ...

Gemtuzumab Ozogamicin - National Cancer Institute

www.cancer.gov/about-cancer/treatment/drugs/gemtuzumabozogamicin

This page contains brief information about gemtuzumab ozogamicin and a collection of links to more information about the use of this drug, research results, and ...

Gemtuzumab Ozogamicin - Drug Information - Chemocare

chemocare.com/chemotherapy/drug-info/gemtuzumab-ozogamicin.aspx

Mylotarg is the trade name for gemtuzumab ozogamicin. In some cases, health care professionals may use the trade name mylotarg when referring to the ...

Gemtuzumab (Mylotarg®) - Macmillan Cancer Support

www.macmillan.org.uk/Cancerinformation/Cancertreatment/Treatmenttypes/Biologicaltherapies/Monoclonalantibodies/Gemtuzumab.aspx

Information about the monoclonal antibody gemtuzumab (Mylotarg®), which is mainly used as part of research trials to treat some types of acute myeloid ...

Mylotarg (gemtuzumab ozogamicin): Market Withdrawal

www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm216458.htm

Jun 21, 2010 ... BACKGROUND: Mylotarg (gemtuzumab ozogamicin), indicated for treatment of acute myeloid leukemia (AML), a bone marrow cancer, was ...

Gemtuzumab Ozogamicin: Time to Resurrect?

jco.ascopubs.org/content/30/32/3921.full

Nov 10, 2012 ... On May 17, 2000, the US Food and Drug Administration (FDA) granted accelerated approval for the use of gemtuzumab ozogamicin (GO) in ...

Blood Journal | Gemtuzumab ozogamicin in acute myeloid leukemia ...

www.bloodjournal.org/content/121/24/4838

Jun 13, 2013 ... Gemtuzumab ozogamicin (GO) consists of a humanized anti-CD33 monoclonal antibody conjugated with calicheamicin, a potent antitumor ...

Gemtuzumab ozogamicin: Indications, Side Effects, Warnings ...

www.drugs.com/cdi/gemtuzumab-ozogamicin.html

Easy to read patient leaflet for gemtuzumab ozogamicin. Includes indications, proper use, special instructions, precautions, and possible side effects.

Gemtuzumab ozogamicin, a potent and selective anti-CD33 ...

www.ncbi.nlm.nih.gov/pubmed/11792178

Bioconjug Chem. 2002 Jan-Feb;13(1):47-58. Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of ...

Approval summary: gemtuzumab ozogamicin in relapsed acute ...

www.ncbi.nlm.nih.gov/pubmed/11410481

PURPOSE: Gemtuzumab ozogamicin (Mylotarg; Wyeth Laboratories, Philadelphia, PA) consists of a semisynthetic derivative of calicheamicin, a cytotoxic ...

Popular Q&A
Q: What is gemtuzumab?
A: Gemtuzumab is a cancer medication. Gemtuzumab interferes with the growth of cancer cells and slows their growth and spread in the body. Gemtuzumab is used to tr... Read More »
Source: www.drugs.com
Q: What is dosage of Gemtuzumab Ozogamicin ?
A: General Consult specialized references for procedures for proper handling and disposal of antineoplastic drugs.1 To minimize risk of tumor lysis syndrome and in... Read More »
Source: www.drugs.com
Q: What is gemtuzumab (Mylotarg)?
A: Gemtuzumab is a cancer medication. Gemtuzumab interferes with the growth of cancer cells and slows their growth and spread in the body. Gemtuzumab is used to tr... Read More »
Source: www.rxlist.com
Q: How to use gemtuzumab Ozogamicin IV
A: This medication is given by injection into a vein by a health care professional. Dosage is based on your body size. This medication is usually given over 2 hour... Read More »
Source: www.webmd.com
Q: How is gemtuzumab given (Mylotarg)?
A: Gemtuzumab is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting. The medicine must be g... Read More »
Source: www.rxlist.com